Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitochondrial DNA as a Biomarker of Sepsis Severity

NCT03077672 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT03077672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03077672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitochondrial DNA as a Biomarker of Sepsis Severity
Lead sponsor
Weill Medical College of Cornell University
Phase
Observational
Overall status
Completed
Start date
February 10, 2017
Completion date
December 22, 2020
Enrollment
1,304 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infection, sepsis, sepsis syndrome, septic shock, severe sepsis